Latent human immunodeficiency virus reactivation
AssigneeThe UAB Research Foundation
InventorsOlaf Kutsch, Michael Niederweis, Frank Wolschendorf, Alexandra Duverger, Frederic Wagner
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe UAB Research Foundation
InventorsOlaf Kutsch, Michael Niederweis, Frank Wolschendorf, Alexandra Duverger, Frederic Wagner
Estimating the term…
Provided herein are methods or reactivating a latent Human Immunodeficiency Virus (HIV) infection in a cell. The methods comprise modulating a level of NF-κB activity in the cell by contacting the cell with an agent that produces a transient first increase in the level of NF-κB activity without a second delayed increase in NF-κB activity. Optionally, a second agent is used to prime the reactivation. Also provided herein is an isolated Massilia bacterium or population thereof capable of producing a HIV-1 reactivating factor (HRF). Also provided are methods of culturing the Massilia bacteria. Further provided are methods of reactivating a latent Human Immunodeficiency Virus-1 (HIV-1) infection in a subject comprising administering to the subject a HIV-1 reactivating factor produced by Massilia bacteria, optionally with a priming agent.
A method of reactivating a latent Human Immunodeficiency Virus (HIV) infection in a cell comprising modulating a level of NF-κB activity in the cell by contacting the cell with a first agent that produces a transient first increase in the level of NF-κB activity without a second delayed increase in NF-κB activity.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of reactivating a latent Human Immunodeficiency Virus (HIV) infection in a subject comprising administering to a subject a HIV reactivating factor (HRF) produced by Massilia bacteria or a reactivating fragment of the HRF produced by Massilia bacteria.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of treating an HIV infection in a subject, the method comprising:
(canceled)
(canceled)
(canceled)
45-52. (canceled)
Dependencies are inferred from the claim text.